Solving the prescription opioid problem

I've posted several times recently on the problem of opioid over-prescription and overdose. Some might assume that I want some regulatory or statutory intervention to address the issue. Truth is, I've got more questions than answers and I would not support a response that forces us to choose between treating pain and preventing addiction and … Continue reading Solving the prescription opioid problem

Overprescription of opioids is bad medicine

Keith Humphreys points out that the problem with the explosion of prescriptions for opioids isn't just addiction and overdose. They are often just not good medicine. Opioids typically have a miraculous effect on acute pain, but this does not necessarily translate to chronic pain relief, particularly as tolerance sets in over time. Even more disturbing, … Continue reading Overprescription of opioids is bad medicine

Less is more – Antipsychotics and Recovery from First-Episode Psychosis

A very interesting finding with profound implications for addicts who experience a psychotic episode. (Particularly since it's so difficult to tease out whether it was substance -induced.) Importance  Short-term outcome studies of antipsychotic dose-reduction/discontinuation strategies in patients with remitted first-episode psychosis (FEP) showed higher relapse rates but no other disadvantages compared with maintenance treatment; however, long-term effects … Continue reading Less is more – Antipsychotics and Recovery from First-Episode Psychosis

Not available?

Another study finds no benefit from cognitive behavioral therapy and contingency management with opiate replacement treatment. [CORRECTED: See below] Background and aims The Controlled Substances Act requires physicians in the United States to provide or refer to behavioral treatment when treating opioid-dependent individuals with buprenorphine; however no research has examined the combination of buprenorphine with … Continue reading Not available?